Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 4
2011 4
2012 4
2013 7
2014 7
2015 4
2016 5
2017 5
2018 8
2019 5
2020 5
2021 5
2022 6
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma.
Mariotto E, Rampazzo E, Bortolozzi R, Rruga F, Zeni I, Manfreda L, Marchioro C, Canton M, Cani A, Magni R, Luchini A, Bresolin S, Viola G, Persano L. Mariotto E, et al. Among authors: bortolozzi r. Acta Neuropathol Commun. 2023 Nov 17;11(1):183. doi: 10.1186/s40478-023-01679-7. Acta Neuropathol Commun. 2023. PMID: 37978570 Free PMC article.
Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold.
Romagnoli R, De Ventura T, Manfredini S, Baldini E, Supuran CT, Nocentini A, Brancale A, Bortolozzi R, Manfreda L, Viola G. Romagnoli R, et al. Among authors: bortolozzi r. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2270180. doi: 10.1080/14756366.2023.2270180. Epub 2023 Oct 18. J Enzyme Inhib Med Chem. 2023. PMID: 37850364 Free PMC article.
Surviving the hunger games: Metabolic reprogramming in medulloblastoma.
Manfreda L, Rampazzo E, Persano L, Viola G, Bortolozzi R. Manfreda L, et al. Among authors: bortolozzi r. Biochem Pharmacol. 2023 Sep;215:115697. doi: 10.1016/j.bcp.2023.115697. Epub 2023 Jul 20. Biochem Pharmacol. 2023. PMID: 37481140 Free article. Review.
Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas.
Barreca M, Spanò V, Rocca R, Bivacqua R, Gualtieri G, Raimondi MV, Gaudio E, Bortolozzi R, Manfreda L, Bai R, Montalbano A, Alcaro S, Hamel E, Bertoni F, Viola G, Barraja P. Barreca M, et al. Among authors: bortolozzi r. Eur J Med Chem. 2023 Jun 5;254:115372. doi: 10.1016/j.ejmech.2023.115372. Epub 2023 Apr 12. Eur J Med Chem. 2023. PMID: 37068384
Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities.
Romagnoli R, Oliva P, Prencipe F, Manfredini S, Budassi F, Brancale A, Ferla S, Hamel E, Corallo D, Aveic S, Manfreda L, Mariotto E, Bortolozzi R, Viola G. Romagnoli R, et al. Among authors: bortolozzi r. Pharmaceuticals (Basel). 2022 Aug 21;15(8):1031. doi: 10.3390/ph15081031. Pharmaceuticals (Basel). 2022. PMID: 36015179 Free PMC article.
Synthesis of 2H-Imidazo[2',1':2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myeloid leukemia (AML) with FLT3/ITD mutations.
Cilibrasi V, Spanò V, Bortolozzi R, Barreca M, Raimondi MV, Rocca R, Maruca A, Montalbano A, Alcaro S, Ronca R, Viola G, Barraja P. Cilibrasi V, et al. Among authors: bortolozzi r. Eur J Med Chem. 2022 May 5;235:114292. doi: 10.1016/j.ejmech.2022.114292. Epub 2022 Mar 16. Eur J Med Chem. 2022. PMID: 35339838
68 results